Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.

S Markowitz; G Krystal; A M Lebacq-Verheyden; J Way; E A Sausville; J Battey

doi:10.1172/JCI113683

National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.

Find articles by Markowitz, S. in: PubMed | Google Scholar

National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.

Find articles by Krystal, G. in: PubMed | Google Scholar

National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.

Find articles by Lebacq-Verheyden, A. in: PubMed | Google Scholar

National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.

Find articles by Way, J. in: PubMed | Google Scholar

National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.

Find articles by Sausville, E. in: PubMed | Google Scholar

National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.

Find articles by Battey, J. in: PubMed | Google Scholar

Published in Volume 82, Issue 3 on September 1, 1988
J Clin Invest. 1988;82(3):808–815. https://doi.org/10.1172/JCI113683.
© 1988 The American Society for Clinical Investigation

Published September 1, 1988 - Version history

The gastrin-releasing peptide (GRP) is a neuropeptide hormone and growth factor produced normally by neural and neuroendocrine cells, as well as by human small-cell lung cancer (SCLC) tumors and derived cell lines. This study compares the structure of the human prepro-GRP gene in four SCLC cell lines that express variable levels of steady-state GRP mRNA. The regulation of GRP gene expression appears to be at the level of primary transcription based on nuclear run on studies. In the two SCLC cell lines expressing GRP we find a single transcription start site for GRP mRNA, and near this site we find four DNase I hypersensitive sites. These hypersensitive sites are absent in the two cell lines that do not express GRP. The presence of DNase hypersensitive sites in the promoter region of the GRP gene is the structural feature that best correlates with transcriptional activation. These four DNase hypersensitive sites are candidates for cis acting regulatory regions, which may be important in determining the level of transcription of the human prepro GRP gene.

Images.

Version 1 (September 1, 1988): No description

Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.

S Markowitz, G Krystal, A M Lebacq-Verheyden, J Way, E A Sausville, and J Battey

Article tools

Metrics

Go to

Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.

S Markowitz, G Krystal, A M Lebacq-Verheyden, J Way, E A Sausville, and J Battey

Article tools

Metrics

Go to

Sign up for email alerts